baber/WOPTO huggingface dataset:
Patent NZ-518764-A (NZ)
Title: Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
Inventor: CHARI RAVI V J
IPC: A61P31/04
Filed: 2000-12-19
Abstract: A cytotoxic agent comprising one or more modified doxorubicins/daunorubicin linked to a cell binding agent. A therapeutic composition for killing selected cell populations comprising: (A) a cytotoxic amount of one or more modified doxorubicins/daunorubicins covalently bonded to a cell binding agent through a linking group, and (B) a pharmaceutically acceptable carrier. A method for killing selected cell populations comprising contacting target cells or tissue containing target cells with an effective amount of a cytotoxic agent comprising one or more modified doxorubicins/daunorubicins linked to a cell binding agent. Novel sulfur-containing modified doxorubicins/daunorubicins.
Patent NZ-523509-A (NZ)
Title: Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
Inventor: COFFEY MATTHEW C
IPC: C12N9/12
Filed: 2001-07-20
Abstract: A method of treating a ras-mediated proliferative disorder in a non-human mammal, comprising the steps of: a) Performing a step selected from the group consisting of: i. Removing B-cells or T cells from said mammal; ii. Removing anti-reovirus antibodies from said mammal; iii. Removing antibodies from said mammal; iv. Administering anti-antireovirus antibodies to said mammal; and v. Suppressing the immune system of said mammal by radiation b) Administering to the proliferating cells in said mammal an effective amount of one or more reoviruses under conditions which result in substantial lysis of the proliferating cells The use of at least one reovirus with at least one of an immune suppressive agent and an anti-antireovirus antibody in the preparation of a medicament for treating a ras-mediated proliferative disorder in a mammal is also described. A pharmaceutical composition comprising an immune suppressive agent, a reovirus and a pharmaceutically acceptable excipient is also disclosed.
Patent NZ-524887-A (NZ)
Title: Ozone treatment apparatus for chemical modification of animal fibers of continuous web form
Inventor: KARAWAKA TADASHI
IPC: D06L4/50
Filed: 2003-03-21
Abstract: A machine for treating animal fibers (e.g. wool) with fine bubbles of ozone to provide the fibers with shrink and pilling resistance. A web of fiber 10 is held between two mesh conveyer belts 12a, 12b that trace a V-shaped path into and out of a bath of treatment liquid. Whilst the web is passing through the bath, a stream of ozone bubbles is pumped through the web and is sucked through the web to the other side of the web by suction ports15a, b and c. This ensures the web is uniformly treated throughout the thickness of the web.
Patent NZ-526989-A (NZ)
Title: Mould and method for injection-compression moulding
Inventor: CLARKE PETER REGINALD
IPC: B29C45/30
Filed: 2002-01-25
Abstract: A metering device is disclosed for use in a plastics moulding machine having a mould cavity, relatively movable platens and a feeding passage for feeding a plastics melt into the mould cavity. The metering device comprises a heated block interposed between the feeding means and the mould cavity. A cylinder with a moving piston is formed in the block. A first passage in the block connects the cylinder to the feeding means and a second passage connects the cylinder to the mould cavity. Valves in the passages enable the cylinder to be filled by the feeding passage without the plastic melt entering the mould cavity and subsequently enable the desired dose of plastics melt, when ejected from the cylinder by the piston, to flow from the cylinder to the mould cavity without being returned to the feeding passage.
Patent NZ-527126-A (NZ)
Title: An antibody that immunospecifically binds G-protein chemokine receptor (CCR5) polypeptide
Inventor: ROSCHKE VIKTOR
IPC: A61K48/00
Filed: 2002-02-08
Abstract: An antibody that immunospecifically binds G-protein Chemokine Receptor (CCR5) polypeptide wherein the antibody comprises an amino acid sequence that is at least 85% or 95% identical to the amino acid sequence of the VH and/or the VL domain of the antibody expressed by the hybridoma cell line deposited under ATCC deposit No. PTA-4054. Also disclosed is the use of the antibody in the preparation of a pharmaceutical composition for the treatment or prevention of specific diseases.
Patent NZ-534479-A (NZ)
Title: Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ACE inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for prolonging lifespan
Inventor: LINZ WOLFGANG
IPC: A61P9/04
Filed: 2003-01-22
Abstract: Disclosed is a cariporide (sodium-hydrogen exchanger) and ramipril (angiotensin converting enzyme inhibitor) combination product. The use of the preparation is disclosed to be for preventing or delaying age-related dysfunctions of organs, especially heart failure, and for prolonging lifespan.
Patent NZ-535235-A (NZ)
Title: Cargo strap flush mount tie down
Inventor: ARMOUR BARRY DOUGLAS
IPC: B61D45/00
Filed: 2004-09-10
Abstract: The tongue 5 of a load anchor 1 can be pivoted from it's flush mounting in the anchor housing 3 (itself flush mounted in the deck or wall of a transport vehicle) by inserting a finger through the tie down strap receiving aperture 13 in the tongue to push on a lever 11 mounted beneath the tongue. The lever pivots to lift the free end of the tongue, the tongue pivoting on trunnions 7, and expose part of the tongue above the top surface of the housing to allow attachment of the tie down strap to the anchor through the tongue aperture.
Patent NZ-538860-A (NZ)
Title: 7-Phenyl pyrazolopyridine compounds
Inventor: HIBI SHIGEKI
IPC: A61P25/20
Filed: 2003-10-22
Abstract: 7-Phenyl pyrazolopyridine compounds represented by the general formula (I), their salts or hydrates thereof are disclosed, wherein R1 represents methoxy, methylthio, methyl, ethyl, or as defined in the specification; R5 and R6 each independently represents cyclopropylmethyl, (4-tetrahydropyranyl)methyl, or as defined in the specification; and two of R40, R41 and R42 are C1-6 alkoxy while the remainder is methoxymethyl, or as defined in the specification. These compounds have an excellent antagonism to a corticotropin-releasing factor receptor, and are suitable for treating depression, a depressive symptom, mania, anxiety, general anxiety disorder, panic disorder, phobia, obsessive-compulsive disorder, posttraumatic stress disorder, Tourette's syndrome, autism, affective disorder, dysthymia, bipolar disorder, cyclothymic personality, schizophrenia, peptic ulcer, irritable bowel syndrome, ulcerative colitis, Crohn's disease, diarrhea, constipation, postoperative ileus, stress-associated gastrointestinal disorder or nervous vomiting.
Patent NZ-543116-A (NZ)
Title: Insect and arachnid trap
IPC: A01M1/24
Filed: 2004-04-26
Abstract: An insect and arachnid trap (10, 100) comprises a substrate (12) having a top surface (14) onto which a sticky substance (24) is deposited. The trap (10, 100) also have a channel (22, 22') into which the sticky substance (24) is deposited. The top surface (14) may have a smooth finish and be inclined to the horizontal in order to prevent trapped insects and arachnids from extricating themselves from the sticky substance. The reinforcing rib ensures that the substrate (12) does not fold back upon itself when handled after use. Contact with trapped insects or arachnids is thus avoided.
Patent NZ-544115-A (NZ)
Title: A milk liner with strengthening ring to space teat engaging flange from udder and cricoid fold
Inventor: HARTY EDMOND PATRICK SR
IPC: A01J5/16
Filed: 2004-05-17
Abstract: A milk liner assembly (1) comprises a milk liner (5) sealably located in an outer shell (3) and defining with the outer shell (3) a pulsating vacuum chamber (23). The milk liner (5) comprises a sleeve (8) and a teat engaging flange (25) which together define a teat receiving cavity (11). A teat accommodating opening (26) through the teat engaging flange (25) accommodates a teat into the teat receiving cavity (11).; A strengthening ring (28) integrally formed with the sleeve (8) is located on the sleeve (8) and extends around the sleeve (8) adjacent the teat engaging flange (25) for minimising excessive radial inward contraction of the sleeve (8), and in turn excessive radial inward contraction of the teat engaging flange (25) onto the teat so that even if the teat engaging flange (25) were to engage the cricoid fold, milk flow through the cricoid fold would not be inhibited by the gripping pressure exerted by the teat engaging flange (25) on the cricoid fold. The strengthening ring (28) extends axially from the sleeve (8), and terminates in a distal abutment surface (30) for abutting the udder of the animal for in turn spacing the teat engaging flange (25) from the udder and from the cricoid fold.
Patent NZ-544482-A (NZ)
Title: 2,4-BIS(trifluoroethoxy)pyridine compound and medicine containing the same
Inventor: SHIBUYA KIMIYUKI
IPC: A61P9/10
Filed: 2004-07-06
Abstract: Disclosed is a 2,4-bis(trifluoroethoxy)pyridine compound represented by the formula (1), (wherein X1 represents a fluorine atom or a hydrogen atom) or a salt as an active ingredient. The compound or salt has metabolic resistance to human hepatic microsome, satisfactory oral absorbability, and excellent ACAT inhibitory activity.
Patent NZ-550891-A (NZ)
Title: Substituted azepine derivatives as serotonin receptor modulators
Inventor: BENNANI YOUSSEF L
IPC: A61K31/55
Filed: 2005-06-29
Abstract: Provided is the compound of the formula below, with specified X and R substituents. These substituted azepine derivatives are useful as serotonin receptor modulators for treatment of e.g. addiction, anxiety, depression and obesity.
Patent NZ-555997-A (NZ)
Title: Method and device for consuming rights objects having inheritance structure
Inventor: OH YUN-SANG
IPC: G06F15/16
Filed: 2006-01-13
Abstract: A digital rights management method and device are provided. To implement the DRM method and device, there is provided a master device including a storage module, detection module, message generation module, device interface module and playback module. The storage module stores a plurality of rights objects (ROs) having an inheritance structure. The detection module searches the storage module for an RO corresponding to a predetermined content object. The message generation module generates an RO request message if the detection module fails to discover the RO corresponding to a predetermined content object from the storage module. The device interface module transmits the RO request message to a slave device and receives the RO corresponding to a predetermined content object from the slave device. The playback module plays back the predetermined content object using the RO corresponding to a predetermined content object from at least one of the storage module and the slave device.
Patent NZ-562849-A (NZ)
Title: Generation of phosphorus oxychloride as by-product from phosphorus pentachloride and DMF and its use for chlorination reaction by converting into vilsmeier-haack reagent
Inventor: RATNAM RAKESH
IPC: C07H5/00
Filed: 2006-04-28
Abstract: Discloses a process of preparation of Vilsmeier-Haack reagent from Phosphorus Pentachloride comprising the steps of: a. reacting N,N-dialkylformamide or N,N-dialkylacetamide, preferably N,N-dialkylformamide, more preferably N,N-dimethylformamide (DMF), with Phosphorus Pentachloride to prepare a first crop of Vilsmeier reagent as insoluble crystals and Phosphorus Oxy-Chloride as by-product, b. allowing the said by-product Phosphorus Oxy-Chloride to further react with DMF to form a second crop of Vilsmeier reagent in the same reaction mixture resulting into a combined Vilsmeier reagent, or, c. isolating the said by-product Phosphorus Oxy-Chloride from the first reaction mixture by one or more of a process of separation comprising distillation and cooling and this isolated Phosphorus Oxy-Chloride is reacted with DMF to prepare second crop of Vilsmeier reagent; which is used for chlorination reaction i. either independently and separately, or ii. after combining with the said first crop of Vilsmeier reagent, or iii. after combining with Vilsmeier reagent formed from reacting DMF with other sources of chlorinating agent.
Patent NZ-568289-A (NZ)
Title: Polymorphs of (R)-3-[1-(2,6-dichloro-3-fluoro-phenyl)-ethoxy]-5-(1- piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine
Inventor: CUI JINGRONG JEAN
IPC: A61K31/4155
Filed: 2006-11-23
Abstract: This disclosure relates to polymorphs of (R)-3-[1-(2,6-dichloro-3-fluoro-phenyl)-ethoxy]-5-(1- piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine that are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This disclosure also relates to compositions including such salts and polymorphs, and their use in the treatment of abnormal cell growth in mammals, especially humans.
Patent NZ-569698-A (NZ)
Title: Anti-MN antibodies and methods of using same
Inventor: TAMBURINI PAUL
IPC: C07K16/28
Filed: 2006-12-12
Abstract: Disclosed is a human antibody or antibody fragment comprising an antigenic binding site comprising a set of heavy chain CDR sequences consisting of SEQ ID NOS: 57, 63, and 70; and a set of light chain CDR sequences consisting of SEQ ID NOS: 89, 93 and 97. Also disclosed is the use of the said antibody or antibody fragment in the preparation of a medicament for the treatment or diagnosis of a condition related to an abnonnal level of MN protein expression.
Patent NZ-575189-A (NZ)
Title: Pickering emulsion formulations
Inventor: FOWLER JEFFREY
IPC: A01N25/04
Filed: 2007-08-30
Abstract: Disclosed is a liquid pesticidal emulsion composition comprising (a) an aqueous continuous phase; (b) at least one colloidal solid; and (c) a dispersed oil emulsion phase comprising at least one substantially water insoluble pesticidally active ingredient, which is either itself an oily liquid comprising the oil phase, is a solid but is dissolved in an oily liquid present in the oil phase, is a solid and is dispersed within the oil phase or is present as a colloidal solid adsorbed to the liquid-liquid interface between the continuous aqueous phase and the dispersed oil phase, and wherein if the composition further comprises an emulsifier formed of a low molecular weight or polymeric surfactant, the composition comprises less than 0.5 weight % of the emulsifier. Also disclosed is a method for combating or preventing pests in crops of plants by applying the above liquid pesticidal emulsion to the desired area.
Patent NZ-593214-A (NZ)
Title: Compounds and Processes for preparing serine protease inhibitors
Inventor: TANOURY GERALD J
IPC: A61K31/403
Filed: 2006-08-18
Abstract: 593214 Disclosed is a process of stabilizing the compound of Formula 4, comprising i) dissolving the compound of Formula 4 in an organic solvent to obtain a solution of the compound of Formula 4, ii) adding an acid to the solution of the compound of Formula 4, and iii) concentrating the solution of the compound of Formula 4 to obtain the compound in a solid form.
Patent NZ-593524-A (NZ)
Title: A nonapeptide with anti-tumour activity
Inventor: HAUG BENGT ERIK
IPC: A61K38/08
Filed: 2009-09-11
Abstract: Disclosed is a peptide useful as an anti-tumour agent, comprising the formula: (I) CCLLCCLLC ; or (II) CLLCCLLCC Wherein C represents a cationic amino acid and L represents an amino acid with a lipophilic R group and in which one of the amino acids having a lipophilic R group is a non-genetically coded amino acid, said compound optionally in the form of a salt, ester or amide. Further disclosed is the use of said peptide in the manufacture of a medicament for use as a vaccine adjuvant, and a pharmaceutical pack comprising at least one vaccine and at least one of said peptide.
Patent NZ-594059-A (NZ)
Title: Heterocyclic-substituted piperidine compounds and the uses thereof
Inventor: BABA YOSHIYASU
IPC: C07D451/14
Filed: 2008-01-15
Abstract: Disclosed is a compound of formula (III) or (IV) which contains a diazepine fused moiety. The substituents are as disclosed in the description. Examples of the compounds are: (Z)-5-(1-(cyclooct-2-enyl)piperidin-4-yl)-7-methoxy-1H-pyrido[2,3-b][1,4]diazepine-2,4(3H,5H)-dione and 5-(1-cyclooctylpiperidin-4-yl)-7-methoxy-1H-pyrido[2,3-b][1,4]diazepine-2,4(3H,5H)-dione. Also disclosed is a composition comprising a compound of formula (III) or (IV), an in-vitro method for modulating ORL comprising administering a compound of formula (III) or (IV), the use of a compound of formula (III) or (IV) in the manufacture of a medicament, a kit comprising a compound of formula (III) or (IV) and a method for preparing a composition comprising admixing a compound of formula (III) or (IV) with an excipient.
Patent NZ-596849-A (NZ)
Title: Serum amyloid p derivatives and their preparation and use
Inventor: CAIMI RICHARD J
IPC: A61K38/17
Filed: 2010-06-04
Abstract: NZ 596849 Disclosed is a recombinant glycosylated human Serum Amyloid P (SAP) polypeptide comprising an N-linked oligosaccharide chain, wherein at least one sialylated branch of the oligosaccharide chain terminates with an alpha-2,3-linked sialic acid moiety.
Patent NZ-597062-A (NZ)
Title: Support structure for a wind turbine
Inventor: MARTINEZ DE CASTANEDA FRANCISCO JAVIER
IPC: F03D11/04
Filed: 2010-05-19
Abstract: 597062 A support structure for a wind turbine is disclosed. The structure is assembled from a series of spans of column shafts (1) with a frusto-conical shape, each span integrating two or more parts (2) and (3) with a polygonal or circular section formed with pieces pre-stressed in a bed in the factory, with centred or slightly deviated pre-stressing (4) and non-pre-stressed reinforcement (5) in the perimeter of the section or fibres. The pieces are attached by means of wet or dry longitudinal joints (6), rotated in plan view or not, and transverse joints (7) which can be at different levels. The present invention is different from the previous proposals, which are generally based on the post-tensioning of cables at the actual point of installation of the tower or wind farm, by providing the tower and the attachment joints with strength by pre-stressing in the factory, calculated according to the relative position that the piece will occupy in the tower or structure. Therefore the pieces forming the tower, by are already by themselves structurally resistant, requiring only the attachments between the adjacent and superimposed wall pieces to form the tower. Furthermore, costs are reduced since pre-stressing in the factory is an industrial process. Additionally the technology applied eliminates the need for auxiliary elements for transport, assures a state of compression in the pieces which maximizes the useful life of the tower, allows new designs and assembly alternatives which simplifies the tower.
Patent NZ-600654-A (NZ)
Title: Power system
Inventor: SHITRIT SHLOMO
IPC: H02P9/00
Filed: 2010-11-18
Abstract: Disclosed is a power system for providing a fast acting spinning reserve. The system includes a turbine module operating in accordance with an organic Rankine cycle coupled to a generator and a main conduit through which motive fluid vapor heated in the organic Rankine cycle is supplied to the turbine module. A flow control component (20) is connected to the main conduit and automatically limits the flow of the motive fluid vapor to the turbine module during base load conditions and automatically increases the flow of the motive fluid vapor to the turbine module during variable load conditions.
Patent NZ-602596-A (NZ)
Title: Improvements in and relating to telescoping members
Inventor: ROGERS JASON PAUL
IPC: F16B7/10
Filed: 2012-09-21
Abstract: 602596 Disclosed is a telescoping assembly which includes a first member attached to a spring button device and a second hollow member with an internal diameter which is larger than the external diameter of the first hollow member. The spring button device has a button end and a biasing component outwardly biasing the button end. The second hollow member includes at least two rows of longitudinally spaced apart apertures extending along the length of the member. The apertures in each row are offset with respect to apertures in a different row so that every aperture is located a different distance from a distal end of the second member. The button end is dimensioned to fit through any of the apertures in the second member when aligned therewith as a consequence of the force imparted by the biasing component to fix the relative position of the two members.
Patent NZ-602852-A (NZ)
Title: Highly-purified soluble thrombomodulin and method for producing same
Inventor: UENO YUJI
IPC: A61K38/00
Filed: 2011-04-28
Abstract: 602852 A method of producing soluble thrombomodulin with a content of host cell-originated proteins being in a ratio of less than 10ng of the proteins per 10,000U of the soluble thrombomodulin, wherein the soluble thrombomodulin is produced by a transformant cell obtained by transfecting a host cell with a DNA containing a nucleotide sequence encoding the soluble thrombomodulin.
Patent NZ-603049-A (NZ)
Title: Temporary formatting and charting of selected data
Inventor: RUBLE BRIAN SCOTT
IPC: G06F3/14
Filed: 2011-04-13
Abstract: Disclosed is a method for automatically temporarily formatting and charting data. The method is performed by receiving a selection of data and determining values within the selected data (315). The method also includes temporarily displaying on a display a chart (334, 336) representing the values from the selected data (315). The chart (334, 336) is automatically created and displayed on the display upon receiving the selection of data.
Patent NZ-603846-A (NZ)
Title: Plant disease control composition and its use
Inventor: MATSUZAKI YUICHI
IPC: A01P3/00
Filed: 2011-04-25
Abstract: Disclosed herein is a plant disease control composition comprising a carboxamide compound of formula (I), wherein R1 represents a hydrogen atom or methyl group, and R2 represents a methyl group, a difluoromethyl group or a trifluoromethyl group, and one or more QoI compounds selected from group (A) consisting of dimoxystrobin, azoxystrobin, fluoxastrobin, pyraclostrobin, kresoximmethyl, picoxystrobin, trifloxystrobin and N-methyl- alpha-methoxyimino-2-[(2,5-dimethylphenoxy)methyl]phenylacetamide; and a method for controlling plant disease which comprises treating a plant, or soil where a plant grows, with an effective amount of said composition.
Patent NZ-609987-A (NZ)
Title: A desk or table
Inventor: KEN WILLIAM PAYNE
IPC: F16B13/04
Filed: 2013-04-29
Abstract: 609987 An attachment mechanism is disclosed by means of which a desk top (2) can be quickly attached to a steel frame (3). Recesses (13) having a plastic side wall are formed in the underside of the top (2). At corresponding locations on the frame (3) are located upstanding fingers (8) each of which has a barb. The desk top or table top (2) is pushed downwardly onto the frame (3) so that the upper ends of the fingers (8) penetrate the recesses. The inter-engagement of the barbs and the walls of the recesses (13) quickly and permanently maintains the top (2) mounted on the frame (3). Such a desk or table is disclosed as complying with a tipping test stipulated by Australian Standards.
Patent NZ-620087-A (NZ)
Title: Safety belt
Inventor: COLLINS LOEL
IPC: B63C9/11
Filed: 2012-06-15
Abstract: Disclosed is a belt (4) for use with a safety harness or lifejacket or wearable buoyancy device, where elastic or resiliently stretchable material maintains tension on the fastener or buckle. The belt comprises a quick release fastening means (5) attached to a first end of the belt for releasably retaining a second end of the belt around a user, and one or more tensioning elements (8) for exerting tension on the first end of the belt proximal to the quick release fastening means (5) such that, when the quick release fastening means (5) is operated by a user to release the safety belt (4), the one or more tensioning elements (8) pulls the quick release fastening means (5) free from the second end.